• LAST PRICE
    0.1500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.1500/ 10
  • Ask / Lots
    0.1600/ 35
  • Open / Previous Close
    --- / 0.1500
  • Day Range
    ---
  • 52 Week Range
    Low 0.1050
    High 0.2400
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaTELO
Telo Genomics Corp
11.2M
-3.9x
---
CanadaHEM
Hemostemix Inc
8.7M
-4.2x
---
CanadaXRTX
XORTX Therapeutics Inc
5.6M
-2.9x
---
CanadaGLOW
Glow Lifetech Corp
7.3M
-1.6x
---
CanadaRKV
Rakovina Therapeutics Inc
7.2M
-1.9x
---
CanadaBETR
BetterLife Pharma Inc
16.2M
-2.7x
---
As of 2024-11-05

Company Information

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.

Contact Information

Headquarters
Mars Centre, 101 College St Suite 200TORONTO, ON, Canada M5G 1L7
Phone
416-673-8487
Fax
204-582-0922

Executives

Chairman of the Board
Guido Baechler
President, Chief Technology Officer
Sherif Louis
Interim Chief Executive Officer, Director, Chair of the Clinical and Scientific Advisory Board
Sabine Mai
Chief Financial Officer
Christopher Ross
Independent Director
Ron Mcglennen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$11.2M
Revenue (TTM)
$0.00
Shares Outstanding
74.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.02
EPS
$-0.04
Book Value
$0.01
P/E Ratio
-3.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.